These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 17177135)
21. Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis. Machura E; Szczepanska M; Ziora K; Ziora D; Swietochowska E; Barc-Czarnecka M; Kasperska-Zajac A Mediators Inflamm; 2013; 2013():760691. PubMed ID: 23476106 [TBL] [Abstract][Full Text] [Related]
22. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans. Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460 [TBL] [Abstract][Full Text] [Related]
23. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients. Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156 [TBL] [Abstract][Full Text] [Related]
24. Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity. Caron-Cantin SM; Martin J; Bastien M; Munkonda MN; Lu H; Cianflone K; Moustarah F; Biertho L; Marceau S; Hould FS; Bussières J; Poirier P Obes Surg; 2013 Nov; 23(11):1806-14. PubMed ID: 23585024 [TBL] [Abstract][Full Text] [Related]
25. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus. Al-Harithy RN; Al-Ghamdi S Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119 [TBL] [Abstract][Full Text] [Related]
26. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243 [TBL] [Abstract][Full Text] [Related]
27. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals. Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552 [TBL] [Abstract][Full Text] [Related]
28. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814 [TBL] [Abstract][Full Text] [Related]
29. RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY. Zaidi SI; Shirwany TA J Ayub Med Coll Abbottabad; 2015; 27(3):552-5. PubMed ID: 26721005 [TBL] [Abstract][Full Text] [Related]
30. The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with type 2 diabetes. Kadoglou NP; Fotiadis G; Kapelouzou A; Kostakis A; Liapis CD; Vrabas IS Diabet Med; 2013 Feb; 30(2):e41-50. PubMed ID: 23078531 [TBL] [Abstract][Full Text] [Related]
31. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance]. Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858 [TBL] [Abstract][Full Text] [Related]
32. The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation. Huang S; Zou D; Peng W; Jiang X; Shao K; Xia L; Tang Y Ann Endocrinol (Paris); 2016 Dec; 77(6):633-640. PubMed ID: 27641081 [TBL] [Abstract][Full Text] [Related]
33. Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study. Yang W; Li Y; Wang JY; Han R; Wang L Cardiovasc Diabetol; 2018 May; 17(1):75. PubMed ID: 29848323 [TBL] [Abstract][Full Text] [Related]
34. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Olszanecka-Glinianowicz M; Madej P; Nylec M; Owczarek A; Szanecki W; Skałba P; Chudek J Clin Endocrinol (Oxf); 2013 Aug; 79(2):238-42. PubMed ID: 23199261 [TBL] [Abstract][Full Text] [Related]
35. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Fernández-Real JM; Moreno JM; Chico B; López-Bermejo A; Ricart W Diabetes Care; 2007 Mar; 30(3):616-21. PubMed ID: 17327330 [TBL] [Abstract][Full Text] [Related]
36. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. Marcinkowska M; Lewandowski KC; Lewiński A; Bieńkiewicz M; Basińska-Lewandowska M; Salata I; Randeva HS Endokrynol Pol; 2007; 58(3):188-94. PubMed ID: 17940983 [TBL] [Abstract][Full Text] [Related]
37. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Gharibeh MY; Al Tawallbeh GM; Abboud MM; Radaideh A; Alhader AA; Khabour OF Diabetes Metab; 2010 Dec; 36(6 Pt 1):443-9. PubMed ID: 20739208 [TBL] [Abstract][Full Text] [Related]
38. Associations between serum apelin-12 levels and obesity-related markers in Chinese children. Ba HJ; Chen HS; Su Z; Du ML; Chen QL; Li YH; Ma HM PLoS One; 2014; 9(1):e86577. PubMed ID: 24475149 [TBL] [Abstract][Full Text] [Related]